End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,405 IDR | -1.75% | +0.36% | -12.73% |
Apr. 01 | PT Kalbe Farma Tbk. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 20 | Nomura Adjusts Kalbe Farma’s Price Target to IDR1,850 From IDR2,500, Keeps at Buy | MT |
Chart calendar PT Kalbe Farma Tbk.
Upcoming events on PT Kalbe Farma Tbk.
Past events on PT Kalbe Farma Tbk.
2024-04-24 | Q1 2024 Earnings Release (Projected) |
2023-10-31 12:34 am | Q3 2023 Earnings Release |
2023-08-07 02:50 am | Q2 2023 Earnings Release |
2023-05-11 | Ex-dividend day for final dividend |
2023-05-02 11:00 pm | Annual General Meeting |
2023-04-28 05:57 am | Q1 2023 Earnings Release |
2023-04-11 07:15 am | Q4 2022 Earnings Release |
2022-10-30 | Q3 2022 Earnings Release |
2022-07-28 | Interim 2022 Earnings Release |
2022-05-30 | Ex-dividend day for final dividend |
2022-05-18 11:00 pm | Annual General Meeting |
2022-04-27 | Q1 2022 Earnings Release |
2022-03-30 | FY 2021 Earnings Release |
2022-03-08 07:30 pm | ASEAN Consumer & Lifestyle Access |
2021-10-24 | Q3 2021 Earnings Release |
2021-07-29 | Interim 2021 Earnings Release |
2021-05-26 11:00 pm | Annual General Meeting |
2021-03-30 | FY 2020 Earnings Release |
2020-12-03 | Ex-dividend day for dividende intermédiaire |
2020-10-29 | Q3 2020 Earnings Call |
Past dividends on PT Kalbe Farma Tbk.
2023-05-11 | Annual 38 IDR |
2022-05-30 | Annual 35 IDR |
2021-06-07 | Final Payment 28 IDR |
2020-12-03 | Interim Payment 6 IDR |
2020-06-01 | Annual 20 IDR |
2019-06-09 | Annual 26 IDR |
2018-06-21 | Annual 25 IDR |
2017-06-12 | Annual 22 IDR |
2016-06-07 | Annual 19 IDR |
2015-05-25 | Annual 19 IDR |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Billions IDR | Released Forecast Spread | 22 636 22 839 -0.89% | 23 113 23 585 -2% | 26 255 25 516 2.9% | 28 934 29 150 -0.74% | 30 449 30 922 -1.53% | 32 452 |
EBITDA Billions IDR | Released Forecast Spread | 3 771 4 017 -6.13% | 4 137 3 992 3.62% | 4 649 4 494 3.46% | 4 946 5 024 -1.55% | 4 360 4 496 -3.01% | 4 803 |
EBIT Billions IDR | Released Forecast Spread | 3 300 3 504 -5.82% | 3 555 3 442 3.3% | 4 021 3 880 3.64% | 4 231 4 368 -3.15% | 3 694 3 743 -1.31% | 4 077 |
Earnings before Tax (EBT) Billions IDR | Released Forecast Spread | 3 348 3 566 -6.11% | 3 628 3 543 2.38% | 4 073 3 977 2.41% | 4 459 4 542 -1.82% | 3 606 3 706 -2.68% | 4 419 |
Net income Billions IDR | Released Forecast Spread | 2 499 2 665 -6.23% | 2 733 2 683 1.87% | 3 074 3 047 0.9% | 3 382 3 488 -3.04% | 2 767 2 828 -2.18% | 3 439 |
EPS IDR | Released Forecast Spread | 53,5 56,8 -5.83% | 58,3 57,1 2.15% | 65,6 64,9 1.12% | 72,7 74,2 -2.02% | 59,8 60,9 -1.83% | 68,8 |
Announcement Date | 27/02/20 | 07/04/21 | 22/02/22 | 28/03/23 | 01/04/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
---|---|---|---|---|---|---|---|---|---|
Net sales Billions IDR | Released Forecast Spread | 7 310 8 027 -8.94% | 7 888 7 960 -0.9% | ||||||
EBITDA Billions IDR | Released Forecast Spread | 1 051 1 328 -20.89% | |||||||
EBIT Billions IDR | Released Forecast Spread | 878 1 155 -24.02% | 979 794 23.3% | ||||||
Earnings before Tax (EBT) Billions IDR | Released Forecast Spread | 843 1 146 -26.4% | 955 771 23.89% | ||||||
Net income Billions IDR | Released Forecast Spread | 786 787 -0.04% | 802 904 -11.24% | 849 905 -6.2% | 897 884 1.44% | 856 935 -8.45% | 673 902 -25.36% | 536 854 -37.23% | 702 656 7.04% |
EPS IDR | Released Forecast Spread | 16,8 16,8 0.06% | 17,3 19,3 -10.47% | 18,3 19,3 -5.08% | 19,3 18,9 2.24% | 18,4 19,9 -7.73% | 14,5 20,9 -30.87% | 11,5 18,2 -36.76% | 15,4 14,9 3.35% |
Announcement Date | 22/02/22 | 29/07/22 | 31/10/22 | 28/03/23 | 28/04/23 | 07/08/23 | 31/10/23 | 01/04/24 |
Past sector events for PT Kalbe Farma Tbk.
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- KLBF Stock
- Calendar PT Kalbe Farma Tbk.